26 results
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
Prevalence of Nonalcoholic ... progressive type of nonalcoholic ... NonAlcoholicSteatoHepatitis #NonAlcoholicFattyLiverDisease ... #Progression #HCC
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
Pathogenesis of Nonalcoholic ... NonAlcoholicSteatoHepatitis #NonAlcoholicFattyLiverDisease
Hydrochloroquine mechanism of action for COVID19 

#Hydrochloroquine #mechanism #COVID19 #pharmacology #HQC
mechanism #COVID19 #pharmacology ... #HQC
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
hepatitis C virus (HCV ... table #treatment #hcv ... HepatitisC #Management #Pharmacology
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Phytonadione), 4-factor PCC ... Andexxa), 4-factor PCC ... anticoagulation #doac #noac #pharmacology
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
4, fibrosis-4; HCC ... #NonAlcoholic #FattyLiver
Guide to Treatment of Hepatitis C with Direct Acting Antivirals.

Here is a pocket guide to initial
initial treatment of HCV ... #Management #Pharmacology ... #HepatitisC #HCV
Lidocaine HCl - sodium channel blocker. Local anesthetic and class 1B antiarrhythmic. Originally developed in 1943
Lidocaine HCl - ... #Pharmacology #Lidocaine
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
For HCV we use different ... /ambcarerx #HCV ... Classes #DAAs #Pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
like chloroquine/HCQ ... EmergencyMedicine #Pharmacology